Integrated Wealth Concepts LLC increased its holdings in shares of Chemed Co. (NYSE:CHE - Free Report) by 25.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,668 shares of the company's stock after purchasing an additional 1,759 shares during the quarter. Integrated Wealth Concepts LLC owned approximately 0.06% of Chemed worth $4,592,000 as of its most recent SEC filing.
Other hedge funds have also added to or reduced their stakes in the company. UMB Bank n.a. boosted its position in Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company's stock valued at $28,000 after purchasing an additional 39 shares during the last quarter. Atala Financial Inc bought a new stake in shares of Chemed during the 4th quarter worth approximately $29,000. CBIZ Investment Advisory Services LLC boosted its holdings in shares of Chemed by 64.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after buying an additional 22 shares during the last quarter. Trust Co. of Vermont bought a new position in shares of Chemed in the fourth quarter valued at $34,000. Finally, Tortoise Investment Management LLC increased its holdings in Chemed by 77.3% during the fourth quarter. Tortoise Investment Management LLC now owns 78 shares of the company's stock worth $41,000 after buying an additional 34 shares during the last quarter. Institutional investors own 95.85% of the company's stock.
Chemed Stock Performance
CHE traded up $9.58 during trading hours on Monday, reaching $565.32. The company's stock had a trading volume of 115,588 shares, compared to its average volume of 98,797. The company's 50-day moving average is $587.84 and its 200-day moving average is $566.56. Chemed Co. has a 52 week low of $512.12 and a 52 week high of $623.61. The firm has a market cap of $8.26 billion, a PE ratio of 28.57, a price-to-earnings-growth ratio of 2.15 and a beta of 0.49.
Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, beating the consensus estimate of $5.59 by $0.04. The firm had revenue of $646.94 million for the quarter, compared to the consensus estimate of $641.78 million. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The company's quarterly revenue was up 9.8% on a year-over-year basis. During the same period in the previous year, the company earned $5.20 earnings per share. Equities analysts anticipate that Chemed Co. will post 21.43 earnings per share for the current fiscal year.
Chemed Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Monday, February 24th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's payout ratio is 9.74%.
Analyst Upgrades and Downgrades
CHE has been the subject of a number of recent analyst reports. Royal Bank of Canada increased their price target on shares of Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research note on Monday. StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a report on Friday, March 7th.
Get Our Latest Stock Report on CHE
Insider Transactions at Chemed
In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the transaction, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. 3.29% of the stock is owned by corporate insiders.
About Chemed
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Stories

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.